Propanc Biopharma, Inc. (NASDAQ: PPCB) announced a share repurchase program authorizing the buyback of up to $5.0 million of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE